News

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. My name is Rochelle, and I will be your ...
Clinical data builds with CR in testicular cancer, enrollment in Phase 2 gastric trial, and new data in PD-1–resistant tumors ...
In their usual habitat, fish are a major food, caught in the water after a brief chase. On land, mink will kill prey larger ...
Drake starred in an ad for his “Summer Mink” fragrance, with the short clip posted to his Instagram. The video sees the ...
A project from Metro Boomin and Curren$y is in the works. The rapper/producer duo took to social media to tease the arrival ...
MiNK Therapeutics Inc (INKT) showcases promising clinical progress and strategic partnerships while navigating financial constraints and funding delays.
Analysts are estimating that MiNK Therapeutics will report an earnings per share (EPS) of $-0.71. MiNK Therapeutics bulls ...
This long and slender animal was not a muskrat. It was a mink! The pond was one of the manmade landscape features that had ...
MiNK Therapeutics, Inc. announced its first-quarter 2025 financial results and highlighted significant progress in its development of allogeneic invariant natural killer T (iNKT) cell therapies.
MiNK Therapeutics reported progress in clinical programs and highlighted imminent partnering proposals intended to extend runway and support its iNKT cell therapy platform. The company continues ...